Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Policy makers urge EU governments to address stroke prevention in national health plans

Policy makers urge EU governments to address stroke prevention in national health plans

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Study identifies possible link between orthostatic hypotension and atrial fibrillation

Patients at highest risk for suffering full-blown ischemic attack less likely to receive optimal care

Patients at highest risk for suffering full-blown ischemic attack less likely to receive optimal care

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

Chronic diseases account for increasing proportion of GPs' workload

Chronic diseases account for increasing proportion of GPs' workload

Study evaluates effect of structured weight reduction program on atrial fibrillation symptoms

Study evaluates effect of structured weight reduction program on atrial fibrillation symptoms

Cardiovascular Institute researchers to showcase 22 abstracts at upcoming AHA Scientific Sessions

Cardiovascular Institute researchers to showcase 22 abstracts at upcoming AHA Scientific Sessions

Topera receives FDA clearance for FIRMap Catheter

Topera receives FDA clearance for FIRMap Catheter

Atrial fibrillation doubles risk of heart attack in women and African Americans

Atrial fibrillation doubles risk of heart attack in women and African Americans

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

WUSTL's Igor Efimov studies new potential treatment for irregular heartbeat

WUSTL's Igor Efimov studies new potential treatment for irregular heartbeat

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

High levels of omega-3 fatty acid consumption may lead to unintended health consequences

High levels of omega-3 fatty acid consumption may lead to unintended health consequences

NIH awards $2.4M to develop innovative robots to aid people with visual and physical impairment

NIH awards $2.4M to develop innovative robots to aid people with visual and physical impairment

Cardiome signs agreement with Algorithm to sell, distribute BRINAVESS

Cardiome signs agreement with Algorithm to sell, distribute BRINAVESS

Binge drinking increases atherosclerotic progression, stroke mortality risk in men

Binge drinking increases atherosclerotic progression, stroke mortality risk in men

New study guides clinicians and policy makers on cost-effectiveness of anticoagulant drugs

New study guides clinicians and policy makers on cost-effectiveness of anticoagulant drugs

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.